Teva Pharmaceuticals allegedly made payments to Michael Reinstein, a Chicago physician, in return for prescribing generic clozapine, an anti-psychotic medication, to thousands or Medicare and Medicaid patients.
The alleged scheme resulted in the submission of more than 100,000 false claims to Illinois Medicaid and Medicare Part D.
“Teva Pharmaceuticals pushed its drug onto thousands of vulnerable patients without regard to their health and at the expense of the state Medicaid program and Illinois taxpayers,” said Madigan.
Under the settlement terms, Teva must pay the federal government close to $15.5 million and the state of Illinois more than $12.1 million, plus interest.
More Articles on False Claims Act:
Halifax to Institute Internal Monitoring as Part of $85M Settlement
West Virginia False Claims Act Dies In House
Case Expanding False Claims Act Exposure May Be Reviewed by Supreme Court
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
